Benzinga's Biggest Movers For The Week Of July 16, 2018

Loading...
Loading...

The data presented below was compiled using a Screener widget and a Newsfeed widget on the Benzinga Pro platform. The Screener is customizable and is available for the pre-market and after-hours sessions in addition the the intraday session. To try out these widgets, sign up for a trial of the Benzinga Pro platform.

Percentage changes in prices below refer to total weekly change.

Biggest Gainers

  • PEDEVCO Corp PED - Gained 64.2 percent this week despite no company news or clear catalyst to explain the price action.
  • Champions Oncology Inc CSBR - Gained 54 percent this week. The stock spiked Tuesday after Craig-Hallum initiated coverage with a Buy rating and $12 price target.
  • SAExploration Holdings Inc SAEX - Up 30 percent. Shares spiked sharply Friday after the company reported entry in a sale order and agreement for bridge financing to fund its Geokinetics asset acquisition.
  • NF Energy Saving Corp NFEC - Shares of this nano-cap energy provider gained 38.1 percent this week despite no company-specific news to explain this price volatility.
  • Avid Bioservices CDMO - Up 33.9 percent. Shares reacted strongly Monday after the company announced a Q4 earnings beat, despite downbeat FY2019 sales outlook.

Biggest Losers

  • CTI BioPharma Corp CTIC - Shares down 43.7 percent after the company discussed a regulatory pathway for Pacritinib during a Type B meeting with the FDA. The regulatory path will include a Phase 3 trial expected to begin in 2018, while the company will request an additional meeting the the FDA following a second interim review of PAC203.
  • China Customer Relations Centers Inc CCRC - Shares lost 43.6 percen. Benzinga hasn't seen any company-specific news items that could justify this price dip.
  • Medigus Ltd MDGS - Down 34.9 percent. Announced an approximately 2.8 million share common stock offering priced at $3.50 per share.
  • Mersana Therapeutics Inc MRSN - Shares lost 24 percent this week. The company Thursday announced a partial clinical hold for its XMT-1522 clinical trial following a patient death.
  • AVEO Pharmaceuticals Inc AVEO - Down 25.7 percent. The company announced a change in guidance from Q3 is the result of PFS events occuring slower than forecasted, combined with patients being removed or "censored" from the PFS event.
Loading...
Loading...
Posted In: After-Hours CenterMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...